Clinical trial

A Study of A4I Antagonist in Patients With Relapsing Multiple Sclerosis.

NCT00104143

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2007-10-01

PhasePHASE2

Study timeline

Study start (unknown)2007-10-01Date precision: month

Registry last updated2016-08-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

A4I AntagonistDRUG

Sponsors & collaborators

Hoffmann-La Rochelead sponsor

Mapped research locations

SofiaBulgaria4 BarcelonaSpain2 MoscowRussia2 Saint PetersburgRussia2 MadridSpain1 WarsawPoland1 PragueCzechia1 SevilleSpain1 VancouverBritish Columbia, Canada1 EdmontonAlberta, Canada1 LondonOntario, Canada1 MálagaSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00104143 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.